Summary:
Click image to enlargeA randomized, double-blind, placebo controlled, parallel arm, multicenter phase 3 study to evaluate the efficacy and safety of Lorundrostat in subjects with uncontrolled hypertension.
Criteria:- Must be over the age of 18
- Must be medically diagnosed with Hypertension
- Must be on 2-5 blood pressure medication
- BMI must be between 18-40
- Cannot be allergic to Lorundrostat
Qualified Participants May Receive:
Qualified participants will receive $800